# Fate Therapeutics Inc: Form 8-K, filed Jun 13, 2022

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2022-06-13
- Accepted by EDGAR: Jun 13, 2022, 16:10 ET
- Period: 2022-06-09
- Accession: 0000950170-22-011554
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000095017022011554/fate-20220609.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000095017022011554/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000095017022011554/fate-20220609.htm

Filed Jun 13, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-011554. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
